APA (7th ed.) Citation

Settelmeier, S., Agranovski, D., Steinhardt, M., Waydhas, S., Gering, I., Cejka, V., . . . Hendgen-Cotta, U. B. (2026). Transthyretin stabilizer therapy increases naturally-occurring antibodies in ATTR cardiomyopathy. Amyloid, 1. https://doi.org/10.1080/13506129.2026.2651299

Chicago Style (17th ed.) Citation

Settelmeier, Stephan, et al. "Transthyretin Stabilizer Therapy Increases Naturally-occurring Antibodies in ATTR Cardiomyopathy." Amyloid 2026: 1. https://doi.org/10.1080/13506129.2026.2651299.

MLA (9th ed.) Citation

Settelmeier, Stephan, et al. "Transthyretin Stabilizer Therapy Increases Naturally-occurring Antibodies in ATTR Cardiomyopathy." Amyloid, 2026, p. 1, https://doi.org/10.1080/13506129.2026.2651299.